54 related articles for article (PubMed ID: 38431566)
1. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD.
Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q
Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer.
Wang Y; Ouyang S; Liu M; Si Q; Zhang X; Zhang X; Li J; Wang P; Ye H; Shi J; Song C; Wang K; Dai L
BMC Cancer; 2024 Mar; 24(1):283. PubMed ID: 38431566
[TBL] [Abstract][Full Text] [Related]
3. Ubiquilin proteins regulate EGFR levels and activity in lung adenocarcinoma cells.
Kurlawala Z; Saurabh K; Dunaway R; Shah PP; Siskind LJ; Beverly LJ
J Cell Biochem; 2021 Jan; 122(1):43-52. PubMed ID: 32720736
[TBL] [Abstract][Full Text] [Related]
4. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response to epidermal growth factor receptor in lung cancer.
Wang Y; Liu F; OuYang S; Liu M; Zhang X; Wang P; Zhao C; Zhang L; Dai L
Immunol Res; 2021 Feb; 69(1):71-80. PubMed ID: 33495907
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer.
Wang Y; Li J; Zhang X; Liu M; Ji L; Yang T; Wang K; Song C; Wang P; Ye H; Shi J; Dai L
Clin Immunol; 2023 Jan; 246():109206. PubMed ID: 36528251
[TBL] [Abstract][Full Text] [Related]
7. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
Front Immunol; 2021; 12():728853. PubMed ID: 35140701
[TBL] [Abstract][Full Text] [Related]
8. Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis.
Shah PP; Saurabh K; Kurlawala Z; Vega AA; Siskind LJ; Beverly LJ
Neoplasia; 2022 Mar; 25():1-8. PubMed ID: 35063704
[TBL] [Abstract][Full Text] [Related]
9. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
10. Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma.
Wang H; Yang X; Sun G; Yang Q; Cui C; Wang X; Ye H; Dai L; Shi J; Zhang J; Wang P
Front Oncol; 2021; 11():661043. PubMed ID: 34568004
[TBL] [Abstract][Full Text] [Related]
11. Abnormally elevated ubiquilin‑1 expression in breast cancer regulates metastasis and stemness via AKT signaling.
Feng X; Cao A; Qin T; Zhang Q; Fan S; Wang B; Song B; Yu X; Li L
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34528694
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]